What's New

Last Posted: Aug 23, 2024

• Effect of CYP3A5 Gene Polymorphisms on Tacrolimus Blood Concentrations and Adverse Events in Allogeneic Hematopoietic Stem Cell Transplant Patients.
  Jia Jiang, et al. Transplantation proceedings 2024 0
• Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMT.
  Razan Mohty, et al. Bone marrow transplantation 2024 0
• Recipient IL-17A polymorphism rs2275913 is associated with acute graft-versus-host disease after single-unit cord blood transplantation.
  Takaaki Konuma, et al. Transplant immunology 2024 0 102096
• Unravelling the potential of TIM-3 gene polymorphism in allogeneic hematopoietic stem cell transplantation - a preliminary study.
  Sylwia Bia?y, et al. Transplant immunology 2024 0 102084
• Clonal Hematopoiesis-Associated Gene Mutations Affect Acute Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation in AML Patients.
  Xiaoxuan Wei, et al. Annals of transplantation 2024 0 e943688
• Effects of CYP3A5 Genotype on Tacrolimus Pharmacokinetics and Graft-versus-Host Disease Incidence in Allogeneic Hematopoietic Stem Cell Transplantation.
  Daniel N Marco, et al. Pharmaceuticals (Basel, Switzerland) 2024 0 (5)
• An International Learning Collaborative Phase 2 Trial for Haploidentical Bone Marrow Transplant in Sickle Cell Disease.
  Adetola A Kassim et al. Blood 2024
• No role of common NOD2 gene variants in predicting sepsis related outcomes in Indian patients undergoing hematopoietic stem cell transplant.
  Aditya Jandial, et al. Medical journal, Armed Forces India 2023 0 (6) 689-693
• Time-dependent analysis of the impact on early cytomegalovirus reactivation of HLA mismatch and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation from related donors in acquired aplastic anemia.
  Fan Lin, et al. Annals of hematology 2023 0
• Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration.
  Tania Jain, et al. Haematologica 2023 0
• Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan.
  Claire Seydoux, et al. Bone marrow transplantation 2023 0
• Haploidentical Donor Blood or Marrow Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms: Results from a North American Collaboration.
  Jain Tania, et al. Research square 2023 0
• Comparison of NK alloreactivity prediction models based on KIR-MHC interactions in haematopoeitic stem cell transplantation.
  Dhuyser Adèle, et al. Frontiers in immunology 2023 0 1028162
• Circulating cell-free mitochondrial DNA as a diagnostic and prognostic biomarker in chronic and late acute graft-versus-host disease in children.
  Azadpour Shima, et al. Experimental hematology 2023 0
• Association Between Cytotoxic T-Lymphocyte Antigen 4 Gene Polymorphisms and Torque Teno Virus Infection After Hematopoietic Stem Cell Transplantation.
  Ramzi Mani, et al. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2017 0 (3) 259-263
• Evolutionary basis of HLA-DPB1 alleles affects acute GVHD in unrelated donor stem cell transplantation.
  Morishima Satoko, et al. Blood 2017 0 (7) 808-817
• Homozygous HLA-C1 is Associated with Reduced Risk of Relapse after HLA-Matched Transplantation in Patients with Myeloid Leukemia.
  Arima Nobuyoshi, et al. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2017 0 (4) 717-725
• Predicting an HLA-DPB1 expression marker based on standard DPB1 genotyping: Linkage analysis of over 32,000 samples.
  Schöne Bianca, et al. Human immunology 2017 0 (1) 20-27
• Direct HLA Genetic Comparisons Identify Highly Matched Unrelated Donor-Recipient Pairs with Improved Transplantation Outcome.
  Vazirabad Ibrahim, et al. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2018 0 (5) 921-931
• Effects of HLA mismatch on cytomegalovirus reactivation in cord blood transplantation.
  Yokoyama Hisayuki, et al. Bone marrow transplantation 2018 0 (7) 1004-1012
• Donor characteristics and hematopoietic stem cell transplantation outcome: experience of a single center in Southern Brazil.
  Paz Alessandra, et al. Hematology, transfusion and cell therapy 2018 0 (2) 136-142
• Donor lymphocyte infusion for prevention of relapse after unmanipulated haploidentical PBSCT for very high-risk hematologic malignancies.
  Gao Xiao-Ning, et al. Annals of hematology 2018 0 (1) 185-193
• The impact of donor and recipient KIR genes and KIR ligands on the occurrence of acute graft-versus-host disease and graft survival after HLA-identical sibling hematopoietic stem cell transplantation.
  Hoseinian Seyed Ahmad, et al. Turkish journal of medical sciences 2018 0 (4) 794-804
• Inosine Monophosphate Dehydrogenase Pharmacogenetics in Hematopoietic Cell Transplantation Patients.
  McCune Jeannine S, et al. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2018 0 (9) 1802-1807
• Impact of early chimerism status on clinical outcome in children with acute lymphoblastic leukaemia after haematopoietic stem cell transplantation.
  Lejman Monika, et al. BMC cancer 2019 0 (1) 1141
• Pharmacokinetic and Pharmacodynamic Markers of Mycophenolic Acid Associated with Effective Prophylaxis for Acute Graft-Versus-Host Disease and Neutrophil Engraftment in Cord Blood Transplant Patients.
  Yoshimura Kazuaki, et al. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2018 0 (7) 1441-1448
• The MHC gamma block matching: Impact on unrelated hematopoietic stem cell transplantation outcome.
  Maskalan Marija, et al. Human immunology 2019 0 (1) 12-17
• Allogeneic Stem Cell Transplantation for FLT3-Mutated Acute Myeloid Leukemia: In vivo T-Cell Depletion and Posttransplant Sorafenib Maintenance Improve Survival. A Retrospective Acute Leukemia Working Party-European Society for Blood and Marrow Transplant Study.
  Bazarbachi Ali, et al. Clinical hematology international 2021 0 (1) 58-74
• Allogeneic Stem Cell Transplantation in Patients With FLT3-ITD Mutated AML: Transplantation in CR1 Is the Decisive Factor for Good Outcome.
  Jindra Pavel, et al. Clinical lymphoma, myeloma & leukemia 2019 0 (7) 462-469
• Short-term clinical outcomes after HLA 1-locus mismatched uPBSCT are similar to that after HLA-matched uPBSCT and uBMT.
  Fuji Shigeo, et al. International journal of hematology 2019 0 (6) 684-693
• Allogeneic HCT for adults with B-cell precursor acute lymphoblastic leukemia harboring IKZF1 gene mutations. A study by the Acute Leukemia Working Party of the EBMT.
  Giebel Sebastian, et al. Bone marrow transplantation 2020 0 (5) 1047-1055
• IMPACT OF HLA-DPB1 MATCHING ON CLINICAL OUTCOMES AFTER HAPLOIDENTICAL-RELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION.
  Jaime-Pérez José C, et al. Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 2020 0 (2) 69-79
• Influence of HLA 1-3-locus mismatch and antithymocyte globulin administration in unrelated bone marrow transplantation.
  Kawamura Koji, et al. Annals of hematology 2020 0 (5) 1099-1110
• [The effect of CYP3A5 gene polymorphism on tacrolimus concentration and adverse events in patients undergoing allogeneic hematopoietic stem cell transplantation].
  Chen X, et al. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2021 0 (10) 828-833
• Association study of candidate DNA-repair gene variants and acute graft versus host disease in pediatric patients receiving allogeneic hematopoietic stem-cell transplantation.
  Uppugunduri C R S, et al. The pharmacogenomics journal 2021 0 (1) 9-18
• Donor Killer Immunoglobulin Receptor Gene Content and Ligand Matching and Outcomes of Pediatric Patients with Juvenile Myelomonocytic Leukemia Following Unrelated Donor Transplantation.
  Rangarajan Hemalatha G, et al. Transplantation and cellular therapy 2021 0 (11) 926.e1-926.e10
• Influential Factors and Efficacy Analysis of Tacrolimus Concentration After Allogeneic Hematopoietic Stem Cell Transplantation in Children with ?-Thalassemia Major.
  Li Chengxin, et al. Pharmacogenomics and personalized medicine 2021 0 1221-1237
• Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia.
  Dholaria Bhagirathbhai, et al. Journal of hematology & oncology 2021 0 (1) 76
• Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantation.
  Oran Betül, et al. Leukemia 2021 0 (1) 257-262
• Haematologic malignancies with unfavourable gene mutations benefit from donor lymphocyte infusion with/without decitabine for prophylaxis of relapse after allogeneic HSCT: A pilot study.
  Zhang Rui, et al. Cancer medicine 2021 0 (10) 3165-3176
• [Clinical Efficacy of the MDS Patients Treated by Allo-HSCT].
  Wang Qing-Yun, et al. Zhongguo shi yan xue ye xue za zhi 2021 0 (1) 172-180
• Cellular senescence marker p16 and NFKB1 gene polymorphisms in lower gastro-intestinal acute graft versus host disease.
  Kuba Adam, et al. Transplant immunology 2022 0 101768
• Comparable survival outcomes with haploidentical stem cell transplantation and unrelated bone marrow transplantation.
  Atsuta Yoshiko, et al. Bone marrow transplantation 2022 0 (12) 1781-1787
• Relationship between certain HLA alleles and the risk of cytomegalovirus reactivation following allogeneic hematopoietic stem cell transplantation.
  Prem Shruti, et al. Transplant infectious disease : an official journal of the Transplantation Society 2022 0 (4) e13879
• Recipient and donor PTX3 rs2305619 polymorphisms increase the susceptibility to invasive fungal disease following haploidentical stem cell transplantation: a prospective study.
  Zhao Chen, et al. BMC infectious diseases 2022 0 (1) 292
• CMV Seropositive Status Increases Heparanase SNPs Regulatory Activity, Risk of Acute GVHD and Yield of CD34 Cell Mobilization.
  Ostrovsky Olga, et al. Cells 2021 0 (12)
• The impact of HLA matching on outcomes of unmanipulated haploidentical HSCT is modulated by GVHD prophylaxis.
  Lorentino Francesca, et al. Blood advances 2018 0 (11) 669-680
• Donor Killer Cell Immunoglobulin-Like Receptor Genotype Does Not Improve Graft-versus-Leukemia Responses in Chronic Lymphocytic Leukemia after Unrelated Donor Transplant: A Center for International Blood and Marrow Transplant Research Analysis.
  Bachanova Veronika, et al. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2018 0 (5) 949-954
• Impacts of thymoglobulin in patients with acute leukemia in remission undergoing allogeneic HSCT from different donors.
  Wakamatsu Manabu, et al. Blood advances 2019 0 (2) 105-115
• The effects of gene polymorphisms on susceptibility to acute GVHD and survival of allogeneic HSCT recipients: IL-10 gene polymorphisms as a more accessible target to predict prognosis.
  Granero Farias Mariela, et al. Human immunology 2020 0 (1) 18-25

More